ALMAJECT
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 27 Jan 2026)
What this means for you
Registered since 14 Apr 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88046319
- Registration number
- 6034506
- Mark type
- Stylized text
- Filed
- 20 Jul 2018
- Published for opposition
- 18 Dec 2018
- Registered
- 14 Apr 2020
- Attorney of record
- GREGG A. PARADISE
Goods and services
- Class 005 — Pharmaceuticals: Injectable pharmaceuticals for treatment of fungal infections, metastatic tumors, cancers, side effects caused by chemotherapy, moderate to severe pain, hypertension, bacterial infections, and bleeding cessation; pharmaceutical preparations, namely, injectable antineoplastic agents, iron chelating agents, sedatives, and muscle relaxants
Owner
- Almaject, Inc., Morristown, NJ, US
- Almaject, Inc., Pine Brook, NJ, US
- Almaject, Inc., Pine Brook, NJ, US
Prosecution history
- 27 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 27 Jan 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 26 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Oct 2025 — TEAS SECTION 8 & 15 RECEIVED
- 14 Apr 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Mar 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 12 Mar 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 31 Jul 2020 — CORRECTION UNDER SECTION 7 - PROCESSED
- 20 Jul 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 May 2020 — TEAS SECTION 7 REQUEST RECEIVED
- 14 Apr 2020 — REGISTERED-PRINCIPAL REGISTER
- 13 Mar 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Mar 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Feb 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Feb 2020 — USE AMENDMENT FILED